Literature DB >> 28424987

Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System.

Fabio Bagante1, Gaya Spolverato1, Matthew Weiss2, Sorin Alexandrescu3, Hugo P Marques4, Luca Aldrighetti5, Shishir K Maithel6, Carlo Pulitano7, Todd W Bauer8, Feng Shen9, George A Poultsides10, Oliver Soubrane11, Guillaume Martel12, B Groot Koerkamp13, Alfredo Guglielmi1, Endo Itaru14, Timothy M Pawlik15.   

Abstract

INTRODUCTION: The role of routine lymphadenectomy for intrahepatic cholangiocarcinoma (ICC) is still controversial. The AJCC eighth edition recommends a minimum of six harvested lymph nodes (HLNs) for adequate nodal staging. We sought to define outcome and risk of death among patients who were staged with ≥6 HLNs versus <6 HLNs.
MATERIALS AND METHODS: Patients undergoing hepatectomy for ICC between 1990 and 2015 at 1 of the 14 major hepatobiliary centers were identified.
RESULTS: Among 1154 patients undergoing hepatectomy for ICC, 515 (44.6%) had lymphadenectomy. On final pathology, 200 (17.3%) patients had metastatic lymph node (MLN), while 315 (27.3%) had negative lymph node (NLN). Among NLN patients, HLN was associated with 5-year OS (p = 0.098). While HLN did not impact 5-year OS among MLN patients (p = 0.71), the number of MLN was associated with 5-year OS (p = 0.02). Among the 317 (27.5%) patients staged according the AJCC eighth edition staging system, N1 patients had a 3-fold increased risk of death compared with N0 patients (hazard ratio 3.03; p < 0.001).
CONCLUSION: Only one fourth of patients undergoing hepatectomy for ICC had adequate nodal staging according to the AJCC eighth edition. While the six HLN cutoff value impacted prognosis of N0 patients, the number of MLN rather than HLN was associated with long-term survival of N1 patients.

Entities:  

Keywords:  ICC; Nodal status; Staging; Surgery

Mesh:

Year:  2017        PMID: 28424987     DOI: 10.1007/s11605-017-3426-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  Liver anatomy: portal (and suprahepatic) or biliary segmentation.

Authors:  C Couinaud
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

2.  Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.

Authors:  Clancy J Clark; Christina M Wood-Wentz; Kaye M Reid-Lombardo; Michael L Kendrick; Marianne Huebner; Florencia G Que
Journal:  HPB (Oxford)       Date:  2011-09       Impact factor: 3.647

3.  Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.

Authors:  Mechteld C de Jong; Hari Nathan; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Todd W Bauer; Dustin M Walters; T Clark Gamblin; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Richard D Schulick; Michael A Choti; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-07-05       Impact factor: 44.544

4.  Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy.

Authors:  Fabio Bagante; Faiz Gani; Gaya Spolverato; Li Xu; Sorin Alexandrescu; Hugo P Marques; Jorge Lamelas; Luca Aldrighetti; T Clark Gamblin; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; J Wallis Marsh; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2015-09-26       Impact factor: 6.113

5.  Value of diffusion-weighted MR imaging in the diagnosis of lymph node metastases in patients with cholangiocarcinoma.

Authors:  Konstantin Holzapfel; Jochen Gaa; Elaine C Schubert; Matthias Eiber; Joerg Kleeff; Ernst J Rummeny; Martin Loos
Journal:  Abdom Radiol (NY)       Date:  2016-10

6.  Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications.

Authors:  Tsuyoshi Igami; Tomoki Ebata; Yukihiro Yokoyama; Gen Sugawara; Yu Takahashi; Masato Nagino
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

7.  Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.

Authors:  R Kluge; F Schmidt; K Caca; H Barthel; S Hesse; P Georgi; A Seese; D Huster; F Berr
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

8.  CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas.

Authors:  Clare J Roche; Mark L Hughes; Conall J Garvey; Fiona Campbell; Donagh A White; Lucie Jones; John P Neoptolemos
Journal:  AJR Am J Roentgenol       Date:  2003-02       Impact factor: 3.959

9.  Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.

Authors:  Alessandro Vitale; Mohamed Moustafa; Gaya Spolverato; Faiz Gani; Umberto Cillo; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2016-03-03       Impact factor: 3.454

10.  Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models.

Authors:  Alexandre Doussot; Mithat Gonen; Jimme K Wiggers; Bas Groot-Koerkamp; Ronald P DeMatteo; David Fuks; Peter J Allen; Olivier Farges; T Peter Kingham; Jean Marc Regimbeau; Michael I D'Angelica; Daniel Azoulay; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2016-06-11       Impact factor: 6.113

View more
  19 in total

1.  Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.

Authors:  Christian Hobeika; François Cauchy; Nicolas Poté; Pierre-Emmanuel Rautou; François Durand; Olivier Farges; Safi Dokmak; Valérie Vilgrain; Maxime Ronot; Valérie Paradis; Olivier Soubrane
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

2.  Laparoscopic Approach to Intrahepatic Cholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging.

Authors:  Sean P Martin; Justin Drake; Michael M Wach; Samantha Ruff; Laurence P Diggs; Jim Y Wan; Zachary J Brown; Reed I Ayabe; Evan S Glazer; Paxton V Dickson; Jeremy L Davis; Jeremiah L Deneve; Jonathan M Hernandez
Journal:  Ann Surg Oncol       Date:  2019-03-20       Impact factor: 5.344

3.  Tumor grade and sex should influence the utilization of portal lymphadenectomy for early stage intrahepatic cholangiocarcinoma.

Authors:  Sean P Martin; Samantha Ruff; Laurence P Diggs; Justin Drake; Reed I Ayabe; Zachary J Brown; Michael M Wach; Seth M Steinberg; Jeremy L Davis; Jonathan M Hernandez
Journal:  HPB (Oxford)       Date:  2018-08-20       Impact factor: 3.647

Review 4.  [Surgical treatment of hepatic tumors-liver resection and transplantation].

Authors:  H Lang; S Heinrich; F Bartsch; F Hüttl; J Baumgart; J Mittler
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

5.  Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Andrea Ruzzenente; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

6.  [Intrahepatic cholangiocarcinoma : Results after 84 resections].

Authors:  H P Neeff; P A Holzner; M Menzel; P Bronsert; A Klock; S A Lang; S Fichtner-Feigl; U T Hopt; F Makowiec
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

7.  Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival.

Authors:  Lu Wu; Diamantis I Tsilimigras; Anghela Z Paredes; Rittal Mehta; J Madison Hyer; Katiuscha Merath; Kota Sahara; Fabio Bagante; Eliza W Beal; Feng Shen; Timothy M Pawlik
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

8.  The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Katiuscha Merath; Malcolm H Squires; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-01-19       Impact factor: 3.452

9.  Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States.

Authors:  Ariella M Altman; Scott Kizy; Schelomo Marmor; Jing Li Huang; Jason W Denbo; Eric H Jensen
Journal:  J Gastrointest Oncol       Date:  2018-10

Review 10.  The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma.

Authors:  Guergana Panayotova; Jarot Guerra; James V Guarrera; Keri E Lunsford
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.